Mirae Asset Global ETFs Holdings
AKBA icon

Mirae Asset Global ETFs Holdings’s Akebia Therapeutics AKBA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$198K Sell
143,247
-3,452
-2% -$4.74K ﹤0.01% 2369
2025
Q4 		$236K Buy
146,699
+6,963
+5% +$14.6K ﹤0.01% 2271
2025
Q3 		$381K Sell
139,736
-9,656
-6% -$32.1K ﹤0.01% 1999
2025
Q2 		$544K Buy
149,392
+11,495
+8% +$31.6K ﹤0.01% 1780
2025
Q1 		$265K Buy
137,897
+11,517
+9% +$23.5K ﹤0.01% 2177
2024
Q4 		$240K Buy
126,380
+12,232
+11% +$21.2K ﹤0.01% 2291
2024
Q3 		$151K Buy
+114,148
New +$152K ﹤0.01% 2512

Other funds holding AKBA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Mirae Asset Global ETFs Holdings's AKBA Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Akebia Therapeutics (AKBA) stake by 2.4% in Q1 2026, selling an estimated $4.74K and leaving 143,247 shares worth $198K. The position accounts for ﹤0.01% of the portfolio, ranked #2369.

Mirae Asset Global ETFs Holdings first reported a position in AKBA in Q3 2024 and has held it in 7 quarters since. The position peaked at $544K in Q2 2025. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 143,247 shares of Akebia Therapeutics worth $198K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings sold 3,452 Akebia Therapeutics shares in Q1 2026, an estimated $4.74K.
  • Akebia Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2369 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Akebia Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Mirae Asset Global ETFs Holdings's Akebia Therapeutics position peaked at $544K in Q2 2025.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.